In T-ALL, gain-of-function mutations occurring at the NOTCH1 gene are found in about 50–60% of patients [10], and high expression of the NOTCH3 gene can frequently be observed in patients’ samples analyzed [11]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.